SULFATE DE MAGNESIUM RENAUDIN 15 %, solution for injection (i.v.) 10 ampoules of 10 ml
Active ingredients: Magnesium sulfate heptahydrate
Commercialized according to BDPM
Solution for injection10 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SULFATE DE MAGNESIUM RENAUDIN 15 %, solution injectable (I.V.)
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) bouteille en verre de 10 ml
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 2018
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65841474CIP73664261CIP133400936642614Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE MAGNÉSIUM HEPTAHYDRATÉsolution | 0,15 g · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.